Parvati Rose Perman-Howe (Parvati R Perman-Howe)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Health Information

Alcohol Consumption

Cross Sectional

Top Venues

Pilot and feasibility studies

Addiction (Abingdon, England)

Drug and alcohol review

King's College London

This page only lists publications with an associated author ORCID identifier.

Affiliation History

King's College London

United Kingdom

Research Associate :: Addictions

Public Health England

United Kingdom

Publications and Information Officer :: National Screening Division

University of Oxford

United Kingdom

Research Assistant :: Primary Care Health Sciences

Nottingham University Hospitals NHS Trust

United Kingdom

Screening Officer - National Bowel Cancer Screening Programme :: Pathology

Publications

Katherine A East, Giang Vu, Tianze Sun BPsyc, Kimberly D'Mello, Parvati Rose Perman-Howe, Eve Taylor, Matilda Kim Nottage, Leonie Sarah Brose, Deborah Robson, Ann McNeill
Harm perceptions across vaping product features: An on-line cross-sectional survey of adults who smoke and/or vape in the United Kingdom. Addiction (Abingdon, England) (2024)
Parvati Rose Perman-Howe, John Holmes, Jamie Brown, Inge Kersbergen
Characteristics of consumers of alcohol-free and low-alcohol drinks in Great Britain: A cross-sectional study. Drug and alcohol review (2024)
Parvati Rose Perman-Howe, Emma L Davies, David R Foxcroft
The effect of alcohol strength on alcohol consumption: findings from a randomised controlled cross-over pilot trial. Pilot and feasibility studies 7 (1) (2021)
Parvati Rose Perman-Howe, Marie Horton, Deborah Robson, Máirtín S McDermott, Ann McNeill, Leonie Sarah Brose
Harm perceptions of nicotine-containing products and associated sources of information in UK adults with and without mental ill health: A cross-sectional survey. Addiction (Abingdon, England) (2021)
Parvati Rose Perman-Howe, Emma L Davies, David R Foxcroft
The effect of alcohol strength on alcohol consumption: a randomised controlled cross-over pilot trial. Pilot and feasibility studies 4 (2018)